OAG
AGN

Orbis Allan Gray’s Allergan plc AGN Stock Holding History

Orbis Allan Gray’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-714,633
Closed -$150M – 77
2016
Q4 		$150M Sell
714,633
-292,945
-29% -$60.7M 1.08% 29
2016
Q3 		$232M Sell
1,007,578
-144
-0% -$35.2K 1.62% 20
2016
Q2 		$233M Buy
1,007,722
+853,855
+555% +$197M 1.77% 18
2016
Q1 		$41.2M Buy
+153,867
New +$44M 0.33% 44

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Orbis Allan Gray's AGN Position: Q1 2017 in Review

Orbis Allan Gray sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 714,633 shares — an estimated $150M sold.

Orbis Allan Gray first reported a position in AGN in Q1 2016 and held it in 4 quarters. The position peaked at $233M in Q2 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Orbis Allan Gray reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Orbis Allan Gray sold 714,633 Allergan plc shares in Q1 2017, an estimated $150M.
  • Orbis Allan Gray first reported a position in Allergan plc in Q1 2016 and held it in 4 quarters.
  • Orbis Allan Gray's Allergan plc position peaked at $233M in Q2 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Orbis Allan Gray's 13F filing for Q1 2017, filed 15 May 2017.